Delaware’s adult use cannabis market generated $53.4 million in first year sales and $8 million in tax revenue, but the state remains far below an earlier $281 million projection. The bigger lesson is that legalization headlines do not guarantee market execution when licensing, zoning, capital, supply, and retail access move slowly.

New York cannabis businesses are asking Gov. Kathy Hochul to veto legislation that would create a Cannabis Wage Board to recommend minimum hourly wages for industry workers. The bigger lesson is that labor policy is becoming a major market stability issue as operators deal with payroll pressure, equity business risk, illicit competition, capital constraints, and compliance costs.

U.S. cannabis sales declined year over year for the first time on record, falling from $32 billion in 2024 to $29.94 billion in 2025. The bigger lesson is that the industry is not facing disappearing demand. It is facing price compression, oversupply, over licensing, and a new phase where margin survival matters more than raw growth.

New York cannabis licensing activity continues with new dispensary openings, 24 adult use license approvals, 36 amendment approvals, 71 adult use renewals, and 15 CAURD renewals. The bigger lesson is that New York operators need strong renewal calendars, clean license records, amendment procedures, and operating readiness as the regulated market expands.

Brazil’s legal medical cannabis market generated R$970.9 million in 2025 and reached more than 873,000 patients in treatment. The bigger lesson is that Brazil is becoming a serious international growth market, but imports, physician education, patient access, product documentation, and regulation will decide who captures the opportunity.

The U.S. legal cannabis workforce declined for the first time, falling to 412,500 jobs in early 2026 as retail revenue slipped to $29.1 billion in 2025. The bigger lesson is that the regulated market is becoming leaner and more mature, forcing operators to focus more on efficiency, margin discipline, and selective growth.

Maryland generated more than $17.5 million in adult use cannabis tax revenue during Q1 2025, with funds flowing to reinvestment, public health, business assistance, local governments, cannabis administration, and the general fund. The bigger lesson is that Maryland’s licensed cannabis market is becoming a meaningful public revenue source.

Germany’s post reclassification medical cannabis market is still one of Europe’s biggest opportunities, but the growth story is more complicated than many operators expected. The bigger lesson is that reimbursement, physician liability, wholesale margin compression, patient behavior, and policy timing will decide who actually wins.

South Africa has demand, operators, and clear cannabis potential, but it still lacks the commercial rules needed to turn legalization into a functioning market. The bigger lesson is that banking access, insurance availability, licensing clarity, and product rules matter just as much as legalization itself.

Morocco’s legal cannabis industry now has more than 140 cannabis based products manufactured and officially registered with the Moroccan Agency for Medicines and Health Products. The bigger lesson is that Morocco is moving from cultivation potential into regulated product manufacturing, export readiness, and international supply chain relevance.

SQDC reported $809.5 million in sales for fiscal 2025 2026, with $132.4 million in net income and a $331.3 million contribution to the Quebec government. The bigger lesson is that government run cannabis retail can keep growing through store expansion, vape access, pricing discipline, and legal market capture.

Trulieve is expected to become the first U.S. cannabis company listed on a major U.S. stock exchange, with shares set to trade on the NYSE under ticker TRLV. The bigger lesson is that major exchange access may now depend on clean restructuring, medical cannabis positioning, DEA registration readiness, and institutional capital credibility.

Michigan’s new 24 percent wholesale cannabis tax generated just under $34 million in Q1 2026, far below the projected fiscal year revenue. The bigger lesson is that aggressive cannabis taxes can backfire when operators already face thin margins, falling sales, closures, layoffs, and local revenue pressure.

Brazil set a new record for medical cannabis imports in March 2026, with more than 61,000 import authorizations granted in the first quarter and 23,199 in March alone. The bigger lesson is that Brazil is becoming a serious medical cannabis growth market, but import dependence, patient authorization rules, and distribution structure will decide who actually captures the opportunity.

Emblem Cannabis is set to acquire Ayurcann assets, including vape and pre roll manufacturing capacity, a Health Canada licensed facility, and national distribution relationships. The bigger lesson is that Canadian cannabis consolidation is still being driven by tax pressure, debt, wholesale compression, and distressed asset strategy.